Genomic Health, Inc. (GHDX) financial statements (2021 and earlier)

Company profile

Business Address 301 PENOBSCOT DRIVE
REDWOOD CITY, CA 94063
State of Incorp.
Fiscal Year End December 31
SIC 8071 - Medical Laboratories (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:214130979510410599
Cash and cash equivalents62464033303318
Short-term investments148845762747281
Other undisclosed cash, cash equivalents, and short-term investments4      
Receivables52313537352922
Prepaid expense and other current assets9
Other undisclosed current assets91414111010 
Total current assets:275174146143149145130
Noncurrent Assets
Property, plant and equipment40464640221814
Long-term investments and receivables4   1412 
Long-term investments4   1412 
Other noncurrent assets1611921614
Prepaid expense and other noncurrent assets9
Other undisclosed noncurrent assets    (14)(12) 
Total noncurrent assets:60575542373224
TOTAL ASSETS:334232201185186177154
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities59394140352723
Accounts payable9039755
Accrued liabilities16141091086
Employee-related liabilities34252822181311
Taxes payable    000
Customer refund liability    111
Deferred revenue and credits  0010
Other liabilities1000000
Other undisclosed current liabilities   2221
Total current liabilities:60404143383025
Noncurrent Liabilities
Liabilities, other than long-term debt4442222
Other liabilities4442222
Total noncurrent liabilities:4442222
Total liabilities:64434545403227
Stockholders' equity
Stockholders' equity attributable to parent270188156140146145126
Common stock0000000
Treasury stock, value(30)(30)(30)(30)(30)(30)(30)
Additional paid in capital507465427395370345314
Accumulated other comprehensive income (loss)(0)(0)13(0)00
Accumulated deficit(206)(246)(242)(228)(195)(170)(158)
Total stockholders' equity:270188156140146145126
TOTAL LIABILITIES AND EQUITY:334232201185186177154

Income statement (P&L) ($ in millions)

12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenues394341328287276262235
Revenue, net341328287276262235
Cost of revenue(49)(55)(57)(54)(49)(42)(37)
Cost of goods and services sold (55)(57)(54)(49)(42)(37)
Gross profit:345286271234227219198
Operating expenses(321)(292)(286)(268)(264)(244)(198)
Other undisclosed operating income    14139
Operating income (loss):24(6)(15)(34)(24)(12)8
Nonoperating income (expense)24(0)(0)(1)(0)0
Investment income, nonoperating2400000
Foreign currency transaction loss, before tax    (1)(0)(0)
Other nonoperating income (expense)(0)0(1)(0)(1)(0)(0)
Income (loss) from continuing operations before equity method investments, income taxes:26(2)(16)(34)(25)(12)9
Loss from equity method investments      (0)
Other undisclosed income (loss) from continuing operations before income taxes1 3 1(0)0
Income (loss) from continuing operations before income taxes:27(2)(13)(34)(24)(12)9
Income tax expense (benefit)(1)(2)(1)1(0)(0)(0)
Net income (loss) available to common stockholders, diluted:26(4)(14)(33)(25)(13)8

Comprehensive Income ($ in millions)

12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net income (loss):26(4)(14)(33)(25)(13)8
Comprehensive income (loss):26(4)(14)(33)(25)(13)8
Other undisclosed comprehensive income (loss), net of tax, attributable to parent0(1)(2)3(0)(0)0
Comprehensive income (loss), net of tax, attributable to parent:26(5)(15)(31)(25)(13)8

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: